Gene · 7031
Papers3,695
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,695
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. | Int J Cancer | 2023 | 36093581 | PubTator, text mining | PubMed |
| A classification of genes involved in normal and delayed male puberty. | Asian J Androl | 2023 | 35532554 | PubTator, text mining | PubMed |
| ERK1/2-RSK regulation of oestrogen homeostasis. | FEBS J | 2023 | 35176205 | PubTator, text mining | PubMed |
| Nanoscale nuclear environments, fine-scale 3D genome organization and transcription regulation. | Curr Opin Syst Biol | 2022 | 37091742 | PubTator, text mining | PubMed |
| Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma. | Front Oncol | 2022 | 36818673 | PubTator, text mining | PubMed |
| Global knowledge mapping and emerging trends in research between spasmolytic polypeptide-expressing metaplasia and gastric carcinogenesis: A bibliometric analysis from 2002 to 2022. | Front Cell Infect Microbiol | 2022 | 36776551 | PubTator, text mining | PubMed |
| A cis-regulatory lexicon of DNA motif combinations mediating cell-type-specific gene regulation. | Cell Genom | 2022 | 36742369 | PubTator, text mining | PubMed |
| Discovery of a potent BTK and IKZF1/3 triple degrader through reversible covalent BTK PROTAC development. | Curr Res Chem Biol | 2022 | 36712232 | PubTator, text mining | PubMed |
| ESR1 fusions and therapeutic resistance in metastatic breast cancer. | Front Oncol | 2022 | 36686845 | PubTator, text mining | PubMed |
| A high interferon gamma signature of CD8+ T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer. | Front Immunol | 2022 | 36685525 | PubTator, text mining | PubMed |
| Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. | World J Gastroenterol | 2022 | 36632312 | PubTator, text mining | PubMed |
| Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer. | J Oncol | 2022 | 36618075 | PubTator, text mining | PubMed |
| Immunoregulatory Role of the Mechanosensitive Ion Channel Piezo1 in Inflammation and Cancer. | Molecules | 2022 | 36615408 | PubTator, text mining | PubMed |
| Coptis, Pinellia, and Scutellaria as a promising new drug combination for treatment of Helicobacter pylori infection. | World J Clin Cases | 2022 | 36579091 | PubTator, text mining | PubMed |
| Phytochemical Compounds and Nanoparticles as Phytochemical Delivery Systems for Alzheimer's Disease Management. | Molecules | 2022 | 36558176 | PubTator, text mining | PubMed |
| Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer. | Curr Issues Mol Biol | 2022 | 36547059 | PubTator, text mining | PubMed |
| Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone in vitro and in vivo. | RSC Chem Biol | 2022 | 36544574 | PubTator, text mining | PubMed |
| AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance. | Cell Rep | 2022 | 36516775 | PubTator, text mining | PubMed |
| IFNγ-dependent silencing of TFF1 during Helicobacter pylori infection. | Open Biol | 2022 | 36514982 | PubTator, text mining | PubMed |
| Different Molecular Forms of TFF3 in the Human Respiratory Tract: Heterodimerization with IgG Fc Binding Protein (FCGBP) and Proteolytic Cleavage in Bronchial Secretions. | Int J Mol Sci | 2022 | 36499686 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7031/papers?page=20